A phase 1 randomized study of hemodynamic effects and pharmacokinetic interactions during concomitant use of rimegepant and sumatriptan in healthy adults

• المؤلفون الرئيسيون: Robert Croop (مؤلف), Andrea Ivans (مؤلف), Matt S Anderson (مؤلف), Joseph Stringfellow (مؤلف), Richard Bertz (مؤلف), Michael Hanna (مؤلف), Francine Healy (مؤلف), David A Stock (مؤلف), Vladimir Coric (مؤلف), Richard B Lipton (مؤلف)
• التنسيق: كتاب
• منشور في: SAGE Publishing, 2021-04-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Objective: This randomized, partially-blinded, placebo-controlled study evaluated hemodynamic effects, pharmacokinetic interactions, and safety of concomitant administration of oral rimegepant and subcutaneous sumatriptan. Methods: Healthy non-smokers aged ≥18 and ≤40 years (men) or ≥18 and ≤50 year...